Clinical profile of HIV/AIDS-infected patients admitted to a new specialist unit in Dhaka, Bangladesh-A low-prevalence country for HIV

Journal of Health, Population and Nutrition

Volumn 29, Issue 1, 2011, Pages 14-19

  Matin, Nashaba ^a   Shahrin, Lubaba ^a   Pervez, Mohammed Moshtaq ^a   Banu, Sayera ^a   Ahmed, Dilruba ^a   Khatun, Mahmuda ^a   Pietroni, Mark ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

Acquired immunodeficiency syndrome; Bangladesh; HIV; Retrospective studies; Tuberculosis

Indexed keywords

EID: 79953084004     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: 10.3329/jhpn.v29i1.7562     Document Type: Article

References (24)

1. Azim T, Khan SI, Nahar Q, Reza M, Alam N, Saifi R et al. 20 years of HIV in Bangladesh: experiences and way forward. Dhaka: World Bank, 2009. 201 p.
2. Azim T, Khan SI, Haseen F, Huq NL, Henning L, Pervez MM et al. HIV and AIDS in Bangladesh. J Health Popul Nutr 2008;26:311-24.
3. Bangladesh. Ministry of Health and Family Welfare. Directorate General of Health Services. National AIDS/STD Programme. 2008 UNGASS country progress report-Bangladesh; reporting period: January 2006-December 2007. Dhaka: National AID/STD Programme, Ministry of Health and Family Welfare, Government of Bangladesh, 2008. 42 p.
4. World Health Organization. Revised WHO clinical staging and immunological classification of HIV and case definition of HIV for surveillance. Geneva: World Health Organization, 2006. (http://www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf, accessed on 30 April 2010).
5. Mercer A, Khanam R, Gurley E, Azim T. Sexual risk behavior of married men and women in Bangladesh associated with husbands' work migration and living apart. Sex Transm Dis 2007;34:265-73.
6. Islam MB. Blood transfusion services in Bangladesh. Asian J Transfus Sci 2009;3:108-10.
7. Phillips AN, Elford J, Sabin C, Bofill M, Janossy G, Lee CA. Immunodeficiency and the risk of death in HIV infection. JAMA 1992;268:2662-6.
8. World Health Organization. Global tuberculosis control-surveillance, planning, financing. Geneva: World Health Organization, 2008. 294 p. (WHO/ HTM/TB/2008.393).
9. Kitkungvan D, Apisarnthanarak A, Plengpart P, Mundy LM. Fever of unknown origin in patients with HIV infection in Thailand: an observational study and review of the literature. Int J STD AIDS 2008;19:232-5.
10. Chacko S, John TJ, Babu PG, Jacob M, Kaur A, Mathai D. Clinical profile of AIDS in India: a review of 61 cases. J Assoc Physicians India1995;43:535-8.
11. Sircar AR, Tripathi AK, Choudhary SK, Misra R. Clinical profile of AIDS: a study at a referral hospital. J Assoc Physicians India1998;46:775-8.
12. World Health Organization. Global tuberculosis database: Bangladesh, 2007. Geneva: World Health Organization, 2007. (http://apps.who.int/globalatlas/ dataQuery/default.asp, accessed on 24 April 2010).
13. Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993;148:1292-7.
14. Chaisson RE, Schecter GF, Theuer CP, Rutherford GW, Echenberg DF, Hopewell PC. Tuberculosis in patients with acquired immunodeficiency syndrome: clinical features, response to therapy, and survival. Am Rev Respir Dis 1987;136:570-4.
15. Ackah AN, Coulibaly D, Digbeu H, Diallo K, Vetter KM, Coulibaly IM et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet 1995;345:607-10.
16. Ribera E, Pou L, Lopez RM, Crespo M, Falco V, Ocaña I et al. Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis. J Acquir Immune Defic Syndr 2001;28:450-3.
17. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984;311:354-8.
18. Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C et al. A controlled trial of trimethoprimsulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med 1992;327:1842-8.
19. Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis 1996;23:125-30.
20. Singh PN, Ranjana K, Singh YI, Singh KP, Sharma SS, Kulachandra M et al. Indigenous disseminated Penicillium marneffei infection in the state of Manipur, India: report of four autochthonous cases. J Clin Microbiol 1999;37:2699-702.
21. Meisheri YV, Mehta S, Patel U. A prospective study of seroprevalence of Toxoplasmosis in general population, and in HIV/AIDS patients in Bombay, India. J Postgrad Med 1997;43:93-7.
22. Hussain A, Rahim MA, Azad Khan AK, Ali SM, Vaaler S. Type 2 diabetes in rural and urban population: diverse prevalence and associated risk factors in Bangladesh. Diabetic Med 22:931-6.
23. Health Protection Agency. Centre for Infections. UK Collaborative Group for HIV and STI Surveillance. Testing times. HIV and other sexually transmitted infections in the United Kingdom: 2007. London:Centre for Infections, Health Protection Agency, 2007. 123 p.
24. Sullivan AK, Curtis H, Sabin CA, Johnson MA. Newly diagnosed HIV infections: review in UK and Ireland. BMJ 2005;330:1301-2.